Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

MiMedx aims to boost R&D with new hire
October 2020
SHARING OPTIONS:

MARIETTA, Ga.—August saw MiMedx Group Inc. expand its management team with the addition of Dr. Robert B. Stein as the company's new executive vice president of research and development. Stein has more than 40 years of experience in drug discovery and development, having previously served at firms such as Merck, Ligand Pharmaceuticals, DuPont-Merck and Incyte Pharmaceuticals, among others.
 
“Throughout my career I’ve been drawn to research efforts and companies that are taking on meaningful and challenging health problems,” said Stein. “MiMedx is taking the next steps to further the science and better understand the clinical potential of placental tissue to bring improved healing to more people in need. My role is to continually enhance the rigor of our strong scientific foundation that will more clearly inform our pipeline and expand the company’s potential to address significant areas of unmet clinical need.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.